Sideroblastic Anemia Pyridoxine-refractory Autosomal Recessive - 20 Studies Found
Completed |
: Differentiation Therapy With Decitabine in Treating Patients With Myelodysplastic Syndrome :
|
Completed |
: Safety and Tolerability Trial of Abatacept-based Immunosuppression for Prevention of Acute Graft Versus Host Disease (aGVHD) During Transplant :
: |
Recruiting |
: A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies :
|
Completed |
: Identification of de Novo Fanconi Anemia in Younger Patients With Newly Diagnosed Acute Myeloid Leukemia :
: Other: laboratory biomarker analysis Correlative studies |
Completed |
: MS-275 and GM-CSF in Treating Patients With Myelodysplastic Syndrome and/or Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphocytic Leukemia :
|
Active, not recruiting |
: Iodine I 131 Monoclonal Antibody BC8, Fludarabine Phosphate, Total Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome :
|
Active, not recruiting |
: Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell Transplant :
|
Active, not recruiting |
: Total-Body Irradiation and Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer :
|